In our studies, however, AKT activation in irradiated prostate tissues does not change upon JNK inhibition ruling out a significant functional contribution of JNK-dependent AKT activation in prostate cancer development in SP-treated β1pc-/- TRAMP mice. The gene discussed is AKT1; the disease is prostate carcinoma.